Viewing Study NCT03434769


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT03434769
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-06
First Post: 2018-02-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
Sponsor: Benjamin Tomlinson
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-09
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-01
Primary Completion Date Type: ACTUAL
Completion Date: 2036-02
Completion Date Type: ESTIMATED
First Submit Date: 2018-02-09
First Submit QC Date: None
Study First Post Date: 2018-02-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-03
Last Update Post Date: 2025-01-06
Last Update Post Date Type: ACTUAL